Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Nov 7, 2018

New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) Injection cardiovascular outcomes trial

* Praluent significantly reduced major adverse cardiovascular events by 15% (p<0.001)
Nov 6, 2018

FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis
Nov 1, 2018

Provention Bio to Report Third Quarter 2018 Financial Results and Host Conference Call on Thursday, November 8, 2018
Oct 31, 2018

Sanofi Q3 2018 Performance Confirms Return to Growth
- Photos 4
Oct 30, 2018

FDA grants priority review for Sanofi's dengue vaccine candidate

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.